Table 3

Complete blood count data of men (A) and women (B) before and following three weeks of supplementation with Ambrotose AO® at a dosage of 4 capsules per day and placebo (cross-over design with a three week washout between conditions).

A


Variable

Trained Men Ambrotose AO® Pre

Trained Men Ambrotose AO® Post

Trained Men Placebo Pre

Trained Men Placebo Post

Untrained Men Ambrotose AO® Pre

Untrained Men Ambrotose AO® Post

Untrained Men Placebo Pre

Untrained Men Placebo Post


WBC (103 μL)†

4.5 ± 0.1

4.5 ± 0.2

5.1 ± 0.6

4.9 ± 0.3

5.7 ± 0.5

6.0 ± 0.4

5.9 ± 0.5

5.6 ± 0.5

RBC (106 μL)*

4.9 ± 0.1

4.7 ± 0.1

4.9 ± 0.1

4.8 ± 0.1

4.7 ± 0.2

4.6 ± 0.2

4.6 ± 0.3

4.6 ± 0.2

Hemoglobin (g·dL-1)*

14.7 ± 0.3

13.3 ± 0.5

14.8 ± 0.4

14.6 ± 0.3

14.8 ± 0.5

14.6 ± 0.5

14.6 ± 0.6

14.4 ± 0.4

Hematocrit (%)†*

43.3 ± 0.8

41.8 ± 1.1

43.5 ± 1.0

42.3 ± 0.5

43.0 ± 1.0

41.9 ± 1.2

42.2 ± 2.0

41.2 ± 1.3

MCV (fL)**

88.7 ± 2.2

89.0 ± 2.5

88.3 ± 2.3

88.3 ± 2.2

91.2 ± 2.6

90.8 ± 2.3

91.6 ± 2.2

91.0 ± 2.5

MCH (pg)**

30.2 ± 1.0

30.5 ± 1.0

29.9 ± 1.0

30.3 ± 0.9

31.4 ± 1.0

31.7 ± 1.0

31.7 ± 1.0

31.9 ± 1.1

MCHC (g·dL-1)**

34.0 ± 0.4

34.2 ± 0.2

33.9 ± 0.4

34.4 ± 0.4

34.5 ± 0.4

34.9 ± 0.3

34.5 ± 0.3

35.0 ± 0.4

RDW (%)**

13.8 ± 0.4

13.2 ± 0.3

13.6 ± 0.3

13.5 ± 0.3

13.0 ± 0.2

13.1 ± 0.2

12.9 ± 0.2

12.9 ± 0.2

Platelets (103 μL)*

208.0 ± 16.7

204.0 ± 13.9

214.4 ± 16.1

211.4 ± 21.7

217.6 ± 20.4

203.2 ± 21.0

208.0 ± 24.5

209.6 ± 24.3

Neutrophils (%)

51.1 ± 4.5

50.0 ± 3.4

52.7 ± 4.9

51.0 ± 4.6

54.2 ± 2.6

58.0 ± 4.6

52.8 ± 2.1

53.6 ± 3.6

Lymphocytes (%)

36.0 ± 3.8

37.4 ± 3.2

36.0 ± 4.4

36.4 ± 4.3

32.6 ± 2.1

30.2 ± 4.1

34.2 ± 1.3

33.5 ± 2.9

Monocytes (%)†

7.7 ± 0.6

8.6 ± 0.8

7.6 ± 0.6

8.3 ± 0.5

7.4 ± 0.9

7.2 ± 1.2

7.0 ± 0.5

7.1 ± 0.9

Eosinophils (%)*

4.9 ± 1.8

3.7 ± 0.8

3.1 ± 0.7

3.9 ± 0.6

5.2 ± 1.6

4.0 ± 1.0

5.8 ± 1.8

5.3 ± 1.8

Basophils (%)

0.3 ± 0.2

0.3 ± 0.2

0.6 ± 0.2

0.4 ± 0.2

0.6 ± 0.2

0.6 ± 0.2

0.2 ± 0.2

0.5 ± 0.2


B


Variable

Trained Women Ambrotose AO® Pre

Trained Women Ambrotose AO® Post

Trained Women Placebo Pre

Trained Women Placebo Post

Untrained Women Ambrotose AO® Pre

Untrained Women Ambrotose AO® Post

Untrained Women Placebo Pre

Untrained Women Placebo Post


WBC (103 μL)†

5.1 ± 1.0

5.2 ± 0.7

4.7 ± 0.4

5.3 ± 0.7

5.6 ± 0.5

4.9 ± 0.3

5.0 ± 0.4

6.0 ± 0.8

RBC (106 μL)*

4.2 ± 0.1

4.1 ± 0.1

4.2 ± 0.1

4.2 ± 0.1

4.2 ± 0.1

4.1 ± 0.1

4.2 ± 0.1

4.2 ± 0.2

Hemoglobin (g·dL-1)*

13.4 ± 0.4

12.8 ± 0.3

13.2 ± 0.1

13.2 ± 0.2

12.5 ± 0.3

12.1 ± 0.4

12.3 ± 0.5

12.4 ± 0.6

Hematocrit (%)†*

38.8 ± 1.0

37.1 ± 0.9

38.6 ± 0.4

37.9 ± 0.6

36.9 ± 0.8

35.0 ± 0.8

36.6 ± 1.4

36.5 ± 1.5

MCV (fL)**

91.9 ± 1.7

91.4 ± 1.8

91.4 ± 2.0

90.8 ± 2.0

87.1 ± 1.2

85.8 ± 0.7

86.5 ± 0.9

86.2 ± 0.9

MCH (pg)**

31.7 ± 0.7

31.6 ± 0.7

31.1 ± 0.7

31.5 ± 0.7

29.6 ± 0.4

29.7 ± 0.4

29.0 ± 0.4

29.3 ± 0.6

MCHC (g·dL-1)**

34.6 ± 0.2

34.6 ± 0.2

34.1 ± 0.2

34.7 ± 0.2

33.9 ± 0.2

34.6 ± 0.3

33.6 ± 0.2

33.9 ± 0.4

RDW (%)**

13.1 ± 0.3

13.3 ± 0.3

13.2 ± 0.2

13.5 ± 0.3

13.3 ± 0.5

13.6 ± 0.6

13.7 ± 0.6

13.7 ± 0.6

Platelets (103 μL)*

234.3 ± 20.0

229.1 ± 17.1

246.1 ± 23.6

236.1 ± 18.8

256.9 ± 29.9

259.2 ± 25.4

254.8 ± 35.6

267.0 ± 34.2

Neutrophils (%)

54.1 ± 5.5

56.3 ± 4.8

57.7 ± 4.7

58.8 ± 3.9

57.3 ± 3.5

56.0 ± 2.0

53.8 ± 3.2

58.3 ± 3.4

Lymphocytes (%)

34.3 ± 4.9

31.0 ± 4.0

30.6 ± 4.4

29.3 ± 3.2

34.3 ± 3.5

35.8 ± 1.8

36.5 ± 2.6

32.5 ± 3.0

Monocytes (%)†

8.0 ± 0.9

9.0 ± 1.0

7.3 ± 0.4

8.4 ± 0.6

6.1 ± 0.5

6.0 ± 0.5

6.2 ± 0.7

5.5 ± 0.8

Eosinophils (%)*

3.0 ± 0.5

3.3 ± 0.9

3.4 ± 0.6

3.0 ± 0.6

1.7 ± 0.5

1.8 ± 0.2

3.0 ± 0.6

2.7 ± 0.5

Basophils (%)

0.6 ± 0.2

0.4 ± 0.2

1.0 ± 0.0

0.5 ± 0.2

0.6 ± 0.2

0.3 ± 0.2

0.5 ± 0.2

0.5 ± 0.2


Values are mean ± SEM.

† Training status effect: WBC (p = 0.02); Hematocrit (p = 0.02); Monocytes (p = 0.0001)

* Sex effect: RBC (p < 0.0001); Hemoglobin (p < 0.0001); Hematocrit (p < 0.0001); Platelets (p = 0.004); Eosinophils (p = 0.002)

** Sex × training status effect: MVC (p = 0.0002); MCH (p < 0.0001); MCHC (p = 0.008); RDW (p = 0.03)

No other statistically significant differences were noted (p > 0.05).

Bloomer et al. Nutrition Journal 2010 9:49   doi:10.1186/1475-2891-9-49

Open Data